Compass Therapeutics, Inc. Stock
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.030 USD | +1.00% |
|
-0.49% | -62.20% |
| Market Cap | 366M 316M 291M 272M 510M 34.75B 518M 3.44B 1.34B 16.91B 1.37B 1.34B 58.56B | P/E Ratio 2026 * |
-4.64x | P/E Ratio 2027 * | -4.39x |
|---|---|---|---|---|---|
| Enterprise Value | 216M 186M 172M 161M 301M 20.49B 306M 2.03B 790M 9.97B 809M 792M 34.53B | EV / Sales 2026 * |
-97.3x | EV / Sales 2027 * | 9.1x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | +1.00% | ||
| 1 week | -0.49% | ||
| Current month | -14.71% | ||
| 1 month | +3.05% | ||
| 3 months | -60.89% | ||
| 6 months | -60.66% | ||
| Current year | -62.20% |
| 1 week | 1.88 |  | 2.1 |
| 1 month | 1.75 | | 2.47 |
| Current year | 1.61 | | 6.88 |
| 1 year | 1.61 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 28/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 09/12/2024 |
Cynthia Sirard
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 01/01/2014 |
Phil Ferneau
BRD | Director/Board Member | 64 | 01/01/2015 |
Carl Gordon
CHM | Chairman | 61 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-29 | Buy | Controller/Auditor | 15,000 | 0.0083% | ||
| 04-29 | Buy | General Counsel | 25,000 | 0.0139% | ||
| 02-08 | Tax | Chief Executive Officer | 36,687 | 0.0206% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.00% | -0.49% | -15.77% | -38.30% | 366M | |
| +1.03% | +2.30% | +55.91% | +114.22% | 56.42B | |
| +2.72% | +3.26% | +46.05% | +44.91% | 44.54B | |
| +1.12% | +2.79% | -15.04% | -21.68% | 22.9B | |
| +1.17% | +3.85% | -0.89% | +403.86% | 21.21B | |
| +3.81% | -5.07% | +11.00% | -30.62% | 16.4B | |
| +0.15% | +2.24% | +9.32% | -39.30% | 15.4B | |
| -0.69% | +0.82% | +27.75% | +176.72% | 13.35B | |
| +5.27% | +5.54% | +19.65% | - | 12.36B | |
| +1.61% | +1.28% | +95.75% | +205.26% | 11.15B | |
| Average | +1.72% | +1.83% | +23.37% | +90.56% | 21.41B | |
| Weighted average by Cap. | +1.72% | +2.36% | +31.96% | +99.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | -2.22M -1.91M -1.76M -1.65M -3.09M -211M -3.14M -20.82M -8.12M -102M -8.31M -8.14M -355M | 25.67M 22.17M 20.43M 19.13M 35.85M 2.44B 36.4M 241M 94.07M 1.19B 96.36M 94.3M 4.11B |
| Net income | -82.94M -71.64M -66.01M -61.79M -116M -7.88B -118M -779M -304M -3.84B -311M -305M -13.29B | -89.49M -77.29M -71.22M -66.67M -125M -8.51B -127M -841M -328M -4.14B -336M -329M -14.34B |
| Net Debt | -150M -130M -119M -112M -209M -14.26B -213M -1.41B -550M -6.94B -563M -551M -24.03B | -132M -114M -105M -98.34M -184M -12.55B -187M -1.24B -484M -6.11B -495M -485M -21.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 2.030 $ | +1.00% | 2,049,688 |
| 11/06/26 | 2.010 $ | +4.69% | 3,589,309 |
| 10/06/26 | 1.920 $ | -6.80% | 3,521,747 |
| 09/06/26 | 2.060 $ | +1.98% | 2,327,289 |
| 08/06/26 | 2.020 $ | -0.98% | 2,267,969 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
